The YouGov study compared two surveys in February and March that asked thousands of respondents if they thought the AstraZeneca vaccine was not safe. As the number in the UK fell from a modest 5% to 9%, France saw negative public perception drop from 43% to 61%, with Germany, Italy and Spain also seeing the majority of their population are suspicious of the vaccine. EU leaders have been criticized by health professionals for suspending the AstraZeneca vaccine rollout over fears of blood clots and have been warned that the break would cost more lives than it would save if people were turning their backs on the coronavirus vaccine.
Distrust of the AstraZeneca vaccine in Europe has been a problem since its inception, with heads of state questioning the effectiveness of the dose.
French President Emmanuel Macron warned the dose was ‘near ineffective’ in people aged 65 and over, while German Chancellor Angela Merkel suspended the rollout for people aged 65 and over due to limited data .
A long-awaited US study published last week looked at the effectiveness of the vaccine, which slightly altered its effectiveness.
But the report was immediately questioned by U.S. Chief Medical Advisor Anthony Fauci for using old data – but urged people to receive the vaccine nonetheless.
A recent YouGov poll suggests that opposition to the AstraZeneca vaccine has had a ripple effect on public confidence and revealed how different countries now view the vaccine.
In France, those who said the AstraZeneca vaccine was not safe increased by 18 points, from 43% to 61%.
In addition, in Germany it went from 40% to 55% and in Spain from 25% to 52%.
According to the YouGov poll, these three big European countries have more citizens who are suspicious of the AstraZeneca vaccine than they trust it.
Some Europeans are now holding out for the Pfizer and Moderna vaccines despite the EU’s continuing feud with AstraZeneca over vaccine supply.
Growing distrust of the AstraZeneca vaccine can be attributed to the recent pause in its deployment due to fears that it is causing fatal blood clots.
However, the World Health Organization (WHO) and the European Medicines Agency have urged countries to reverse their decisions after publishing research whose use was “safe and effective.”
The AstraZeneca vaccine is the main dose used in the UK with over 30 million people vaccinated also using a combination of Pfizer and Moderna doses.
AstraZeneca also wanted to create the vaccine at cost and in a way that allowed developing and poorer countries to access it.
The vaccine does not require extremely cold storage and is relatively inexpensive to manufacture.
It is also one of the main doses used in the WHO COVAX program, which provides the poorest countries with a guaranteed supply of vaccines.
Lord Norman Tebbit says EU ‘arrogance’ justifies Brexit [REACTION]
Take note of the EU! Serbia deploys vaccine stock to neighbors [UPDATE]
EU accused of ‘piracy’ over AstraZeneca threat [OPINION]
But European Commission President Ursula von der Leyen has sparked a giant feud between member states and the UK after threatening to impose vaccine export bans on countries with high vaccination rates.
The Commission claims that AstraZeneca is not fulfilling its contractual supply obligations in Europe and is giving priority to other groups.
But as vaccine reluctance increases against the AZ vaccine, it has been revealed that millions of doses remain unused in storage across Europe as some countries struggle to distribute them.
AstraZeneca insiders have revealed that the company will not consider repeating its model at cost after seeing the profitability of its rivals and the headaches they have endured.
The UK is said to be in talks with Ireland to share doses with them once the UK vaccination program is completed.
Prime Minister Boris Johnson has also offered to share Dutch-made vaccines destined for the UK with the EU to quell any risk of an escalating vaccine war.